Premenstrual Syndrome Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Analgesics, Antidepressants, Oral Contraceptives and Ovarian Suppression Agents, Others); Type (Prescription, OTC); Distribution Channel (Hospital Pharmacy, Drug Store and Retail Pharmacy, Online Providers), and Geography

Report Code: TIPRE00013510 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Premenstrual syndrome (PMS) shows a broader range of symptoms, such as mood swings, food cravings, fatigue, irritability, depression, and tender breasts. It is commonly seen among three of every four menstruating women and experienced some form of premenstrual syndrome. It is caused due to cyclic changes in hormones, changes in neurotransmitters, and depression. It can be treated by medication, altering lifestyles, and habits.

MARKET DYNAMICS

The market for the premenstrual syndrome treatment market is anticipated to grow due to key factors such as increasing incidences premenstrual syndrome due to changing lifestyles, irregular schedules that lead stress, and growing development in the pharmaceutical industry. The market is likely to have good growth opportunities due to rising awareness about the treatment and growing support from governments for women's welfare.

MARKET SCOPE

The "Premenstrual Syndrome Treatment Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of premenstrual syndrome treatment market with detailed market segmentation by product, type, and distribution channel. The premenstrual syndrome treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in premenstrual syndrome treatment market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The premenstrual syndrome treatment market is segmented on the basis of product, type, and distribution channel. On the basis of product, the market is classified as analgesics, antidepressants, oral contraceptives and ovarian suppression agents, and others. Based on type, the market is segmented as prescription, and OTC. And based on distribution channel, the market is divided as hospital pharmacy, drug store and retail pharmacy, and online providers.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the premenstrual syndrome treatment market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The premenstrual syndrome treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting premenstrual syndrome treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Premenstrual syndrome treatment market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the premenstrual syndrome treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Premenstrual syndrome treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for Premenstrual syndrome treatment in the global market. Below mentioned is the list of few companies engaged in the Premenstrual syndrome treatment market.

The report also includes the profiles of key players in premenstrual syndrome treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  ABBVIE INC.
  •  AstraZeneca plc.
  •  BASF Corporation
  •  Bayer AG
  •  Dr. Reddy's Laboratories Ltd
  •  Eli Lilly And Company
  •  GlaxoSmithKline Plc.
  •  H. Lundbeck A/S
  •  Pfizer Inc.
  •  Shionogi Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Premenstrual Syndrome Treatment Market - By Product
1.3.2 Premenstrual Syndrome Treatment Market - By Type
1.3.3 Premenstrual Syndrome Treatment Market - By Distribution Channel
1.3.4 Premenstrual Syndrome Treatment Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PREMENSTRUAL SYNDROME TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PREMENSTRUAL SYNDROME TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PREMENSTRUAL SYNDROME TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. PREMENSTRUAL SYNDROME TREATMENT - GLOBAL MARKET OVERVIEW
6.2. PREMENSTRUAL SYNDROME TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PREMENSTRUAL SYNDROME TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. ANALGESICS
7.3.1. Overview
7.3.2. Analgesics Market Forecast and Analysis
7.4. ANTIDEPRESSANTS
7.4.1. Overview
7.4.2. Antidepressants Market Forecast and Analysis
7.5. ORAL CONTRACEPTIVES AND OVARIAN SUPPRESSION AGENTS
7.5.1. Overview
7.5.2. Oral Contraceptives and Ovarian Suppression Agents Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. PREMENSTRUAL SYNDROME TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
8.1. OVERVIEW
8.2. TYPE MARKET FORECASTS AND ANALYSIS
8.3. PRESCRIPTION
8.3.1. Overview
8.3.2. Prescription Market Forecast and Analysis
8.4. OTC
8.4.1. Overview
8.4.2. OTC Market Forecast and Analysis
9. PREMENSTRUAL SYNDROME TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACY
9.3.1. Overview
9.3.2. Hospital Pharmacy Market Forecast and Analysis
9.4. DRUG STORE AND RETAIL PHARMACY
9.4.1. Overview
9.4.2. Drug Store and Retail Pharmacy Market Forecast and Analysis
9.5. ONLINE PROVIDERS
9.5.1. Overview
9.5.2. Online Providers Market Forecast and Analysis
10. PREMENSTRUAL SYNDROME TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Premenstrual Syndrome Treatment Market Overview
10.1.2 North America Premenstrual Syndrome Treatment Market Forecasts and Analysis
10.1.3 North America Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Product
10.1.4 North America Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Type
10.1.5 North America Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Premenstrual Syndrome Treatment Market
10.1.6.1.1 United States Premenstrual Syndrome Treatment Market by Product
10.1.6.1.2 United States Premenstrual Syndrome Treatment Market by Type
10.1.6.1.3 United States Premenstrual Syndrome Treatment Market by Distribution Channel
10.1.6.2 Canada Premenstrual Syndrome Treatment Market
10.1.6.2.1 Canada Premenstrual Syndrome Treatment Market by Product
10.1.6.2.2 Canada Premenstrual Syndrome Treatment Market by Type
10.1.6.2.3 Canada Premenstrual Syndrome Treatment Market by Distribution Channel
10.1.6.3 Mexico Premenstrual Syndrome Treatment Market
10.1.6.3.1 Mexico Premenstrual Syndrome Treatment Market by Product
10.1.6.3.2 Mexico Premenstrual Syndrome Treatment Market by Type
10.1.6.3.3 Mexico Premenstrual Syndrome Treatment Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Premenstrual Syndrome Treatment Market Overview
10.2.2 Europe Premenstrual Syndrome Treatment Market Forecasts and Analysis
10.2.3 Europe Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Product
10.2.4 Europe Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Type
10.2.5 Europe Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Premenstrual Syndrome Treatment Market
10.2.6.1.1 Germany Premenstrual Syndrome Treatment Market by Product
10.2.6.1.2 Germany Premenstrual Syndrome Treatment Market by Type
10.2.6.1.3 Germany Premenstrual Syndrome Treatment Market by Distribution Channel
10.2.6.2 France Premenstrual Syndrome Treatment Market
10.2.6.2.1 France Premenstrual Syndrome Treatment Market by Product
10.2.6.2.2 France Premenstrual Syndrome Treatment Market by Type
10.2.6.2.3 France Premenstrual Syndrome Treatment Market by Distribution Channel
10.2.6.3 Italy Premenstrual Syndrome Treatment Market
10.2.6.3.1 Italy Premenstrual Syndrome Treatment Market by Product
10.2.6.3.2 Italy Premenstrual Syndrome Treatment Market by Type
10.2.6.3.3 Italy Premenstrual Syndrome Treatment Market by Distribution Channel
10.2.6.4 Spain Premenstrual Syndrome Treatment Market
10.2.6.4.1 Spain Premenstrual Syndrome Treatment Market by Product
10.2.6.4.2 Spain Premenstrual Syndrome Treatment Market by Type
10.2.6.4.3 Spain Premenstrual Syndrome Treatment Market by Distribution Channel
10.2.6.5 United Kingdom Premenstrual Syndrome Treatment Market
10.2.6.5.1 United Kingdom Premenstrual Syndrome Treatment Market by Product
10.2.6.5.2 United Kingdom Premenstrual Syndrome Treatment Market by Type
10.2.6.5.3 United Kingdom Premenstrual Syndrome Treatment Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Premenstrual Syndrome Treatment Market Overview
10.3.2 Asia-Pacific Premenstrual Syndrome Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Type
10.3.5 Asia-Pacific Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Premenstrual Syndrome Treatment Market
10.3.6.1.1 Australia Premenstrual Syndrome Treatment Market by Product
10.3.6.1.2 Australia Premenstrual Syndrome Treatment Market by Type
10.3.6.1.3 Australia Premenstrual Syndrome Treatment Market by Distribution Channel
10.3.6.2 China Premenstrual Syndrome Treatment Market
10.3.6.2.1 China Premenstrual Syndrome Treatment Market by Product
10.3.6.2.2 China Premenstrual Syndrome Treatment Market by Type
10.3.6.2.3 China Premenstrual Syndrome Treatment Market by Distribution Channel
10.3.6.3 India Premenstrual Syndrome Treatment Market
10.3.6.3.1 India Premenstrual Syndrome Treatment Market by Product
10.3.6.3.2 India Premenstrual Syndrome Treatment Market by Type
10.3.6.3.3 India Premenstrual Syndrome Treatment Market by Distribution Channel
10.3.6.4 Japan Premenstrual Syndrome Treatment Market
10.3.6.4.1 Japan Premenstrual Syndrome Treatment Market by Product
10.3.6.4.2 Japan Premenstrual Syndrome Treatment Market by Type
10.3.6.4.3 Japan Premenstrual Syndrome Treatment Market by Distribution Channel
10.3.6.5 South Korea Premenstrual Syndrome Treatment Market
10.3.6.5.1 South Korea Premenstrual Syndrome Treatment Market by Product
10.3.6.5.2 South Korea Premenstrual Syndrome Treatment Market by Type
10.3.6.5.3 South Korea Premenstrual Syndrome Treatment Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Premenstrual Syndrome Treatment Market Overview
10.4.2 Middle East and Africa Premenstrual Syndrome Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Type
10.4.5 Middle East and Africa Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Premenstrual Syndrome Treatment Market
10.4.6.1.1 South Africa Premenstrual Syndrome Treatment Market by Product
10.4.6.1.2 South Africa Premenstrual Syndrome Treatment Market by Type
10.4.6.1.3 South Africa Premenstrual Syndrome Treatment Market by Distribution Channel
10.4.6.2 Saudi Arabia Premenstrual Syndrome Treatment Market
10.4.6.2.1 Saudi Arabia Premenstrual Syndrome Treatment Market by Product
10.4.6.2.2 Saudi Arabia Premenstrual Syndrome Treatment Market by Type
10.4.6.2.3 Saudi Arabia Premenstrual Syndrome Treatment Market by Distribution Channel
10.4.6.3 U.A.E Premenstrual Syndrome Treatment Market
10.4.6.3.1 U.A.E Premenstrual Syndrome Treatment Market by Product
10.4.6.3.2 U.A.E Premenstrual Syndrome Treatment Market by Type
10.4.6.3.3 U.A.E Premenstrual Syndrome Treatment Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Premenstrual Syndrome Treatment Market Overview
10.5.2 South and Central America Premenstrual Syndrome Treatment Market Forecasts and Analysis
10.5.3 South and Central America Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Product
10.5.4 South and Central America Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Type
10.5.5 South and Central America Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Premenstrual Syndrome Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Premenstrual Syndrome Treatment Market
10.5.6.1.1 Brazil Premenstrual Syndrome Treatment Market by Product
10.5.6.1.2 Brazil Premenstrual Syndrome Treatment Market by Type
10.5.6.1.3 Brazil Premenstrual Syndrome Treatment Market by Distribution Channel
10.5.6.2 Argentina Premenstrual Syndrome Treatment Market
10.5.6.2.1 Argentina Premenstrual Syndrome Treatment Market by Product
10.5.6.2.2 Argentina Premenstrual Syndrome Treatment Market by Type
10.5.6.2.3 Argentina Premenstrual Syndrome Treatment Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PREMENSTRUAL SYNDROME TREATMENT MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. PREMENSTRUAL SYNDROME TREATMENT MARKET, KEY COMPANY PROFILES
13.1. ABBVIE INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ASTRAZENECA PLC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BASF CORPORATION
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BAYER AG
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. DR. REDDY'S LABORATORIES LTD
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ELI LILLY AND COMPANY
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. GLAXOSMITHKLINE PLC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. H. LUNDBECK A/S
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. PFIZER INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. SHIONOGI INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. ABBVIE INC.
2. AstraZeneca plc.
3. BASF Corporation
4. Bayer AG
5. Dr. Reddy's Laboratories Ltd
6. Eli Lilly And Company
7. GlaxoSmithKline Plc.
8. H. Lundbeck A/S
9. Pfizer Inc.
10. Shionogi Inc.
TIPRE00013510
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking